Multiplexed Detection of Cytokines Based on Dual Bar-Code Strategy and Single-Molecule Counting

Wei Li1, Wei Jiang2, Shuang Dai1

  • 1Key Laboratory of Natural Products Chemical Biology, Ministry of Education, School of Pharmacy, Shandong University , Jinan, 250012, P. R. China.

Analytical Chemistry
|January 2, 2016
PubMed

Insights

This study introduces a novel dual bar-code assay for sensitive, simultaneous detection of cytokines like interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α). The method achieves a 5 fM detection limit, showing promise for early clinical diagnosis.

Area of Science:

  • Biomarker Discovery
  • Immunotechnology
  • Nanotechnology

Background:

  • Cytokines are crucial immune biomarkers, but single-analyte detection lacks diagnostic specificity.
  • Accurate and sensitive cytokine detection is vital for early disease diagnosis.

Purpose of the Study:

  • To develop a multiplexed cytokine detection method using a dual bar-code strategy and single-molecule counting.
  • To enhance sensitivity and specificity for simultaneous detection of key cytokines.

Main Methods:

  • Constructed magnetic nanoprobes functionalized with antibodies and primary bar-code strands.
  • Utilized a multibranched hybridization chain reaction (mHCR) for signal amplification via secondary bar-codes.
  • Employed multimolecule-labeled fluorescence probes and single-molecule counting for quantification.

Main Results:

  • Achieved excellent sensitivity with a 5 fM detection limit for both interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α).
  • Demonstrated simultaneous detection of two cytokines, surpassing typical bar-code assay limitations.
  • Validated the method's reliability through analysis in human serum samples.

Conclusions:

  • The developed dual bar-code assay offers a direct, sensitive, and specific method for multiplexed cytokine detection.
  • This strategy holds significant potential for advancing early clinical diagnosis and biomarker research.

Related Concept Videos